STING and Nonnecroptotic MLKL-Mediated Mechanisms Improve Dendritic Cell Maturation and Killing of Cancer Cells

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• The cGAS-STING pathway is crucial for antitumor immunity, mediating dendritic cell (DC) maturation.
• DC maturation involves engulfing extracellular DNA from dying cancer cells, activating the cGAS-STING pathway.
• Necroptosis, a programmed inflammatory cell death, can occur when apoptosis is inhibited and contributes to extracellular DNA in tumors.

Purpose of the Study:

• To investigate the role of caspase inhibition in DC maturation and its interaction with the cGAS-STING and necroptosis pathways.
• To explore the potential of targeting these pathways for cancer immunotherapy.

Main Methods:

• Utilized co-cultures of DCs and cancer cells.
• Investigated signaling pathways including caspase, RIPK1/3, MLKL, STING, and TNF-α.
• Assessed DC maturation and cell death, and cancer cell necroptosis.

Main Results:

• Caspase inhibition activates a RIPK1/3, MLKL, and STING signaling axis in DCs, leading to maturation without cell death.
• This caspase inhibition-induced DC maturation promotes TNF-α secretion.
• The secreted TNF-α subsequently induces necroptosis in cancer cells.

Conclusions:

• A novel collaborative mechanism exists between the STING and necroptosis pathways in DC maturation.
• The RIPK1-RIPK3-MLKL pathway's role in this context is non-necroptotic for DCs but promotes necroptosis in cancer cells.
• These findings suggest new therapeutic targets for cancer immunotherapy by modulating DC maturation and necroptosis.